IASLC shared a post on X:
“Register for LALCA24, to learn more about Genomic Markers and Targeted Therapies! You will gain invaluable perspectives on addressing critical disparities in the region, arming yourself with actionable insights to drive change and enhance patient outcomes.”
Read further.
Source: IASLC/X